Pure Biologics S.A. (WSE:PUR)

Poland · Delayed Price · Currency is PLN

1.878

-0.022 (-1.16%)

May 27, 2026, 1:40 PM CET

Revenue by Segment

Financials in millions PLN. Fiscal year is January - December.

Millions PLN. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Innovation in The Field of Biotechnology			662.00K	254.00K	572.00K	-	-
Innovation in The Field of Biotechnology Growth			160.63%	-55.59%	-	-	-
Total			662.00K	254.00K	572.00K	-	-
Total Growth			160.63%	-55.59%	-	-	-

Revenue by Geography

Financials in millions PLN. Fiscal year is January - December.

Millions PLN. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Export			399.00K	205.00K	153.00K	305.00K	262.83K
Export Growth			94.63%	33.99%	-49.84%	16.04%	-41.09%
Poland			263.00K	49.00K	420.00K	1.47M	1.01M
Poland Growth			436.73%	-88.33%	-71.47%	45.95%	88.28%
Total			662.00K	254.00K	573.00K	1.78M	1.27M
Total Growth			160.63%	-55.67%	-67.75%	39.77%	29.49%

Source: S&P Global Market Intelligence.